Dow Corning Boosts Implant Liability Fund Offer To $3 bil.
This article was originally published in The Gray Sheet
Dow Corning would establish a $3 bil. implant liability fund under the firm's third proposed bankruptcy reorganization plan, filed Feb. 17 with the U.S. Bankruptcy Court in Bay City, Michigan.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.